STAT News' Adam Feuerstein, On Benzinga's PreMarket Prep, When Asked About Influence Of Politics/D.C. On Biotech Moving Forward, Says, 'You could see a lot more rhetoric around drug pricing, etc. heading into mid-term elections in Nov.'